Morphological Differential Diagnosis of Primary Myelofibrosis and Essential Thrombocythemia with Computer Cluster Analysis of a Megakaryocytic Lineage in Myeloid Tissue
Authors:
- 1 July 2020
- journal article
- research article
- Published by Pleiades Publishing Ltd in Biophysics
- Vol. 65 (4) , 676-680
Abstract
The DBSCAN clustering algorithm, an in-house method of unsupervised machine learning, was used to explore specific histotopographical features of the megakaryocytic lineage in the bone marrow biopsies of patients with JAK2- or CALR-mutated essential thrombocythemia and prefibrotic primary myelofibrosis. Ninety-five bone marrow biopsies of patients with essential thrombocythemia and primary myelofibrosis were investigated to assess the histotopography of megakaryocytes, specifically, the mean number of megakaryocytes in one cluster, as well as the mean number of clusters and megakaryocytes per 1 mm2 of section area. The logistic regression model was statistically significant: χ2 = 14.703, p = 0.023, Nagelkerke R2 = 19.6%. Analysis of the histotopographical features of megakaryocytes allowed correct differentiation between essential thrombocythemia and primary myelofibrosis in 71.6% cases. The differences in the histotopographical features of megakaryocytes in the bone marrow of with JAK2- or CALR-mutated essential thrombocythemia and primary myelofibrosis revealed by the DBSCAN clustering algorithm indicate that a relationship exists between the disease and the pattern of megakaryocytic lineage development that can be used to create a logistic regression model for differentiating these diseases.Keywords
This publication has 14 references indexed in Scilit:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- WHO‐histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomesBritish Journal of Haematology, 2014
- Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsLaboratory Investigation, 2014
- World Health Organization‐defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations—The Danish experienceAmerican Journal of Hematology, 2013
- European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosisHaematologica, 2011
- Reproducibility of Histologic Classification in Nonfibrotic Myeloproliferative NeoplasiaAmerican Journal of Clinical Pathology, 2011
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International StudyJournal of Clinical Oncology, 2011
- Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classificationBlood, 2011
- Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosisHistopathology, 2010
- Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypesBlood, 2008